Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by Pareto8020on Feb 15, 2024 7:04pm
116 Views
Post# 35883144

RE:Good to see some buying today

RE:Good to see some buying todayYes we are now @ 20 months and not even a peep out of AbbVie on using the TFC-1036 compound yet. 

And I imagine we'd see a milestone payment prior to the compound being used in their products so that doesn't bode well for it hitting the shelves soon.  Who the heck knows when AbbVie is going to get moving on its use - next to zero details were released about the deal so as usual us SBM shareholders aka mushrooms are being left in the dark on so many fronts.

Not a great way to run a public company - figure the biotech industry out as you go, tell the shareholders there is something big about to rocket the company to another level and then go silent for 6 or so months.  I so can't wait until this thing finally has some revenue, the shareprice finally has a dollar symbol in front of it and I can finally part with my shares that are growing old with me.  
<< Previous
Bullboard Posts
Next >>